BIOMAT Database Logo BIOMAT Database Logo

Synthesis of (Z)-(1-fluoro-2-hydroxymethylcyclopropylmethyl)purines. 2003

Ju-Hyun Park, and Young Rang Lee, and Moon Woo Chun, and Lak Shin Jeong, and Chong-Kyo Lee, and Hee-Doo Kim
College of Pharmacy, Sookmyung Women's University, Yongsangu, Seoul, Korea.

(Z)-(1-fluoro-2-hydroxymethylcyclopropylmethyl)purines were designed, synthesized and evaluated their antiviral activity against poliovirus, HSV, and HIV.

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011687 Purines A series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases. They include ADENINE and GUANINE, constituents of nucleic acids, as well as many alkaloids such as CAFFEINE and THEOPHYLLINE. Uric acid is the metabolic end product of purine metabolism.
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D018139 Simplexvirus A genus of the family HERPESVIRIDAE, subfamily ALPHAHERPESVIRINAE, consisting of herpes simplex-like viruses. The type species is HERPESVIRUS 1, HUMAN. Herpes Simplex Virus,Herpesvirus 1, Saimiriine,Herpesvirus 1, Saimirine,Herpesvirus 16, Cercopithecine,Marmoset Virus,Cercopithecine Herpesvirus 16,Herpes Labialis Virus,Herpes-T Virus,Herpesvirus 1 (alpha), Saimirine,Herpesvirus Hominis,Herpesvirus Papio 2,Herpesvirus Platyrhinae,Marmoset Herpesvirus,Saimiriine Herpesvirus 1,Herpes Labialis Viruses,Herpes Simplex Viruses,Herpes T Virus,Herpes-T Viruses,Herpesvirus Homini,Herpesvirus, Marmoset,Herpesviruses, Marmoset,Homini, Herpesvirus,Hominis, Herpesvirus,Labialis Virus, Herpes,Labialis Viruses, Herpes,Marmoset Herpesviruses,Marmoset Viruses,Platyrhinae, Herpesvirus,Saimirine Herpesvirus 1,Simplexviruses,Virus, Herpes Labialis,Viruses, Herpes Labialis

Related Publications

Ju-Hyun Park, and Young Rang Lee, and Moon Woo Chun, and Lak Shin Jeong, and Chong-Kyo Lee, and Hee-Doo Kim
Synthesis of [1'-fluoro-2',2'-bis-(hydroxymethyl)cyclopropylmethyl]purines as antiviral agents.
January 2003, Nucleosides, nucleotides & nucleic acids,
Ju-Hyun Park, and Young Rang Lee, and Moon Woo Chun, and Lak Shin Jeong, and Chong-Kyo Lee, and Hee-Doo Kim
Stereoselective synthesis of (Z)-2-fluoro-1-alkenyl(phenyl)iodonium tetrafluoroborates.
February 2003, Organic letters,
Ju-Hyun Park, and Young Rang Lee, and Moon Woo Chun, and Lak Shin Jeong, and Chong-Kyo Lee, and Hee-Doo Kim
Stereoselective synthesis of (E)- and (Z)-Fluoroalkenylboronates using 2-fluoroalkylideneiodonium ylides generated from (2-fluoro-1-alkenyl)iodonium salts.
December 2007, The Journal of organic chemistry,
Ju-Hyun Park, and Young Rang Lee, and Moon Woo Chun, and Lak Shin Jeong, and Chong-Kyo Lee, and Hee-Doo Kim
(E)-1-[(2-Fluoro-phen-yl)imino-meth-yl]-2-naphthol-(Z)-1-[(2-fluoro-phen-yl)amino-methyl-idene]naphthalen-2(1H)-one (0.57/0.43).
April 2010, Acta crystallographica. Section E, Structure reports online,
Ju-Hyun Park, and Young Rang Lee, and Moon Woo Chun, and Lak Shin Jeong, and Chong-Kyo Lee, and Hee-Doo Kim
Nucleosides. CXXXV. Synthesis of some 9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-9H-purines and their biological activities.
February 1989, Chemical & pharmaceutical bulletin,
Ju-Hyun Park, and Young Rang Lee, and Moon Woo Chun, and Lak Shin Jeong, and Chong-Kyo Lee, and Hee-Doo Kim
4-Fluoro-benzyl (Z)-2-(2-oxoindolin-3-yl-idene)hydrazine-1-carbodi-thio-ate.
March 2024, IUCrData,
Ju-Hyun Park, and Young Rang Lee, and Moon Woo Chun, and Lak Shin Jeong, and Chong-Kyo Lee, and Hee-Doo Kim
(Z)-1-[4-Fluoro-2-(pyrrolidin-1-yl)phen-yl]-3-phenyl-2-(1H-1,2,4-triazol-1-yl)prop-2-en-1-one.
June 2012, Acta crystallographica. Section E, Structure reports online,
Ju-Hyun Park, and Young Rang Lee, and Moon Woo Chun, and Lak Shin Jeong, and Chong-Kyo Lee, and Hee-Doo Kim
Rapid synthesis of 3-[18F]fluoro-1-(2'-nitro-1'-imidazolyl)-2-propanol ([18F]fluoromisonidazole).
March 1994, Pharmaceutical research,
Ju-Hyun Park, and Young Rang Lee, and Moon Woo Chun, and Lak Shin Jeong, and Chong-Kyo Lee, and Hee-Doo Kim
(Z)-1,1-Dicyano-2-(4-fluoro-phen-yl)-3-(1-hexyl-pyridin-1-ium-4-yl)prop-2-en-1-ide.
January 2012, Acta crystallographica. Section E, Structure reports online,
Ju-Hyun Park, and Young Rang Lee, and Moon Woo Chun, and Lak Shin Jeong, and Chong-Kyo Lee, and Hee-Doo Kim
1-(2-Fluoro-benz-yl)-1-(2-fluoro-benz-yl-oxy)urea.
January 2009, Acta crystallographica. Section E, Structure reports online,
Copied contents to your clipboard!